AVE avecho biotechnology limited

the sce report, page-4

  1. 6,655 Posts.
    Top of the morning bio and welcome to the madhouse.

    I agree in the main that the SCE report is very good with one caveat.

    Look I'm no genius, as is evident by my previous posts,but for the life of me I don't understand the inclusion of a cap raising assumption at 11c per share and the deafening silence from the company on that point.

    I am interested in your point of view on that as you have obviously taken time to study the report in detail.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
-0.001(12.5%)
Mkt cap ! $11.10M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $453 129.4K

Buyers (Bids)

No. Vol. Price($)
40 33486086 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 8328117 7
View Market Depth
Last trade - 13.52pm 04/07/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.